Your browser doesn't support javascript.
loading
Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score.
Bsteh, Gabriel; Hegen, Harald; Riedl, Katharina; Altmann, Patrick; Auer, Michael; Berek, Klaus; Di Pauli, Franziska; Ehling, Rainer; Kornek, Barbara; Monschein, Tobias; Rinner, Walter; Schmied, Christiane; Wurth, Sebastian; Zebenholzer, Karin; Zinganell, Anne; Zrzavy, Tobias; Zulehner, Gudrun; Deisenhammer, Florian; Rommer, Paulus; Leutmezer, Fritz; Berger, Thomas.
Afiliação
  • Bsteh G; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Hegen H; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Riedl K; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Altmann P; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Auer M; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Berek K; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Di Pauli F; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Ehling R; Department of Neurology, Clinic for Rehabilitation Münster, Münster, Austria.
  • Kornek B; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Monschein T; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Rinner W; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Schmied C; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Wurth S; Department of Neurology, Medical University of Graz, Graz, Austria.
  • Zebenholzer K; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Zinganell A; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Zrzavy T; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Zulehner G; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Deisenhammer F; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Rommer P; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Leutmezer F; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Berger T; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Eur J Neurol ; 28(5): 1609-1616, 2021 05.
Article em En | MEDLINE | ID: mdl-33370478

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria